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Background: Cells are exposed to multiple stressors that induce significant alterations in signaling pathways and in
the cellular state. As obligate parasites, all viruses require host cell material and machinery for replication. Virus
infection is a major stressor leading to numerous induced modifications. Previous gene array studies have
measured infected cellular transcriptomes. More recently, mass spectrometry-based quantitative and comparative
assays have been used to complement such studies by examining virus-induced alterations in the cellular
proteome.
Methods: We used SILAC (stable isotope labeling with amino acids in cell culture), a non-biased quantitative
proteomic labeling technique, combined with 2-D HPLC/mass spectrometry and reciprocal labeling to identify and
measure relative quantitative differences in HeLa cell proteins in purified cytosolic and nuclear fractions after
reovirus serotype 3 Dearing infection. Protein regulation was determined by z-score analysis of each protein’s label
distribution.
Results: A total of 2856 cellular proteins were identified in cytosolic fractions by 2 or more peptides at >99%
confidence and 884 proteins were identified in nuclear fractions. Gene ontology analyses indicated up-regulated
host proteins were associated with defense responses, immune responses, macromolecular binding, regulation of
immune effector processes, and responses to virus, whereas down-regulated proteins were involved in cell death,
macromolecular catabolic processes, and tissue development.
Conclusions: These analyses identified numerous host proteins significantly affected by reovirus T3D infection.
These proteins map to numerous inflammatory and innate immune pathways, and provide the starting point for
more detailed kinetic studies and delineation of virus-modulated host signaling pathways.
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BioinformaticsBackground
The cellular proteome (the total protein repertoire, which
includes how each protein may be co-translationally or
post-translationally modified) is affected by numerous
stresses, including infection by viruses. Numerous previ-
ous microarray studies have determined how cellular
transcriptomes respond after virus infection (see for ex-
ample: [1,2]). However, since mRNA levels cannot provideCorrespondence: kcoombs@cc.umanitoba.ca
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reproduction in any medium, provided the orcomplete information about levels of protein synthesis or
the types and degrees of post-translational modifications,
there frequently is little concordance between microarray
and protein data [3-5]. Therefore, quantitative and com-
parative proteomic analyses are also being used to provide
additional information about host alterations to virus in-
fection (reviewed in: [6,7]). Commonly used methods
include 2-dimensional difference in gel electrophoresis
(2D-DIGE (see for examples: [8,9]), isotope coded affinity
tags (ICAT; [10,11]), isobaric tags for relative and absolute
quantitation (iTRAQ; [12,13]), and stable isotope labeling
by amino acids in cell culture (SILAC; [14-18]). The
SILAC method involves labeling cells with “light” (normal;
L) and “heavy” (H) isotopic forms of amino acids.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mental set-up is relatively simple, L and H samples are
mixed together early in this process, thereby reducing
sample-to-sample variability, and, if 12C6-Lys and
12C6
14N4-
Arg (L), and 13C6-Lys and
13C6
15N4-Arg (H) amino acids
are used, virtually every tryptic peptide should contain a
labeled amino acid, thereby providing increased protein
coverage. Indeed, several early comparative studies sug-
gested SILAC provided more identifications than the other
commonly used methods (reviewed in [7]). We have been
using SILAC to measure comparative proteomic alter-
ations induced by influenza virus in A549 [19] and in nor-
mal human bronchial epithelial (NHBE) airway cells [20].
We have also begun similar analyses with reovirus-infected
cells, focusing initially upon reovirus serotype T1L-infected
HEK-293 cells [21].
The mammalian reoviruses (MRV) are non-enveloped
viruses with a genome that consists of 10 segments
of double-stranded (ds)RNA. The dsRNA genome is
enclosed in a double-layered concentric protein capsid
composed of 8 viral structural proteins. For reviews, see
[22-24]. MRV is the prototype member of the Ortho-
reovirus genus in the family Reoviridae. The Ortheo-
reoviruses include nonfusogenic MRV and fusogenic
avian reovirus. The Reoviridae family also contains rota-
viruses [25], orbiviruses [26], and at least 9 other gen-
era, several of which can infect animals, insects and/or
plants [23,24]. MRV infections are generally mild in
humans but many of the other family members are
highly pathogenic in their hosts. MRV currently consist
of 4 identified serotypes, with each represented by a
prototype strain: strain Lang (T1L) for serotype 1; strain
Jones (T2J) for serotype 2, strain Dearing (T3D) for
serotype 3 and strain Ndelle for serotype 4 [27]. The
reoviruses have long served as models for understand-
ing viral pathogenesis [22] and they have also been iden-
tified as potential oncolytic agents [28-30] because of
their capacity to selectively kill cancer cells that contain
activated Ras pathway and functional p53 [28,31].
MRV are capable of infecting a wide range of cells,
including mouse L929 cells, often used for stock pre-
paration and titration [32], and various human cells, in-
cluding HEK-293 [21]. Numerous reovirus studies have
also been performed in HeLa cells (see for examples:
[33-36]). Global microarray analyses of MRV-infected
cellular transcriptomes detected activation of numerous
cellular genes, including many related to apoptosis
[37-41]. These microarray assays have recently been
complemented by quantitative and comparative prote-
omic analyses. For example, Li and colleagues recently
demonstrated, using 2D-DIGE, that MRV-infected mur-
ine myocytes regulate several proteins, including heat
shock proteins and interferon-response proteins [42].
We have also shown, using SILAC and 2D-HPLC/MS,that proteins involved in cell death, cell growth and pro-
liferation, molecular transport, gene expression, and in-
flammatory response pathways are affected in MRV
T1L-infected HEK-293 cells [21]. Similar pathways were
also found regulated in a preliminary analysis of reovirus
T3D-infected HeLa cells that concluded that inclusion
of Proteominer® bead-based non-biased enrichment did
not significantly improve proteomic coverage of unpuri-
fied cell extracts [43].
Thus, as part of an ongoing systematic delineation of
reovirus-induced comparative host protein responses, we
are examining how reoviruses T1L and T3D, two of the
most commonly used MRV strains, affect various permis-
sive cells. We have extended our previous T1L-infected
HEK-293 cell study [21] to T3D-infected HEK-293 cells
(Berard, in preparation). Our previous proteomic analysis
of HeLa cells infected with T3D concluded that inclusion
of Proteominer® bead-based non-biased enrichment did
not significantly improve proteomic coverage of unpuri-
fied cell extracts [43]. Therefore, the current study extends
these previous studies by examining proteomic alterations
in purified cytosolic and nuclear fractions in order to glo-
bally assess sub-cellular protein distribution. Reciprocal
labeling also was incorporated to identify probable con-
taminants which were removed from the analyses. We also
extended previous protein identification by more detailed
follow-up kinetic studies of some selected important pro-
teins. This study identified and measured 2856 cytosolic
proteins by 2 or more peptides at >99% confidence and
884 nuclear proteins. DAVID™ and IPA™ ontological ana-
lyses identified significantly up- and down-regulated pro-
teins as well as significantly affected canonical pathways.
Materials and methods
Cells and viruses
Cell lines and media
Mouse L929 fibroblast cells (L929) were grown in sus-
pension in Joklik’s modified minimal essential medium
(J-MEM) (Gibco, Grand Island, NY) supplemented to
contain 5% fetal bovine serum (FBS) (Invitrogen Canada
Inc., Burlington, Ontario), and 2 mM L-glutamine as de-
scribed [32]. Cells were sub-cultured daily.
Human HeLa cells were cultured as monolayers in
Dulbecco’s modified MEM (D-MEM) supplemented
with 0.2% (w/v) glucose, 10% FBS (Invitrogen), 2 mM
l-glutamine, non-essential amino acids, and sodium pyru-
vate. Cells were sub-cultured 2 – 3 times each week.
Viruses
Reovirus strain Type 3 Dearing (T3D) is a laboratory
stock. There are two commonly-used clones of T3D; the
Cashdollar strain (T3DC) and the Fields strain (T3DF).
We elected to use the T3DF strain because a large num-
ber of genetic reagents, including temperature-sensitive
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reassortants [46-48] were generated from this clone.
Virus stocks were usually grown in L929 cell monolayers
in J-MEM in the presence of 5% CO2 at 37°C as above,
but with 3% FBS, 100 U/ml of penicillin, 100 μg/ml
streptomycin sulfate and 100 μg/ml amphotericin-B as
previously described [32].
Virus purification
Large quantities of reovirus T3D were grown in suspen-
sion L929 cell cultures and purified by routine pro-
cedures that make use of Vertrel-XF™ extraction and
cesium chloride ultracentrifugation [49]. Purified virions
were harvested and dialyzed against D-Buffer (150 mM
NaCl, 15 mM MgCl2, 10 mM Tris, pH 7.4). Virus con-
centration was measured by optical density at 260 nm,
using the relationship 1 ODU = 2.1 × 1012 particles per
milliliter [34] and infectivity was titrated.
Infections
Sets of HeLa cells were infected with gradient-purified
T3D at a multiplicity of infection (MOI) of 7 PFU per cell.
For routine infections not destined for SILAC analysis
(i.e. for photomicrography, virus growth kinetic determi-
nations, or Western blot analyses – see below), cells were
harvested at various time points (0 – 72 hours post infec-
tion; hpi), then fractionated as described below.
For SILAC labeling, HeLa cells were adapted through
3 passages (=6 doublings) into D-MEM media provided
in a SILAC™ Phosphoprotein Identification and Quantifi-
cation Kit (Invitrogen Canada Inc.; Burlington, Ontario),
supplemented as above (except without non-essential
amino acids), and with 10% dialyzed FBS (Invitrogen),
plus 100mg each of normal (L; 12C6-lysine and
12C6-/
14N4-arginine) or “heavy” (H;
13C6-lysine [6.0Da differ-
ence] and 13C6-/
15N4-arginine [10.0Da] difference) per
liter of D-MEM. Once HeLa cells had grown through six
doublings in appropriate SILAC media, sets of cells were
infected with gradient-purified T3D or were mock infec-
ted with diluent. Cells were overlaid with appropriate
SILAC media and cultured for 24 hours. In one experi-
ment (Run #1) the L cells were infected and the H cells
were mock infected, whereas H cells were infected and
L cells were mock infected in the reciprocal labeling
experiment (Run #2).
Microscopy
HeLa cells were allowed to attach to 6-well culture
dishes or onto sterile glass cover slips in 6-well culture
dishes and incubated overnight at 37°C. Cells, at ap-
proximately 70% confluency, were washed twice with 1X
PBS and T3D was added to each culture at an MOI of 7.
Virus was adsorbed to cells on ice for one hour to
ensure infection synchronization. Mock-infected cellsreceived only diluent. Cells were overlaid with complete
pre-warmed media and cells were then incubated for
various periods of time from 0 to 72 hours at 37°C.
Infections were monitored at various times and ali-
quots taken for cell viability determinations, using try-
pan blue and ensuring > 200 cells were counted at each
time point, and for virus titrations. Cell monolayers were
also examined with a Nikon TE-2000 and cells were
photographed with a Canon-A700 digital camera. Im-
ages were imported into Adobe and slight adjustments
made in brightness and contrast, but which did not alter
image context with respect to each other.
Cell fractionation
Infected and mock-infected cells were harvested at various
times post-infection and counted. Aliquots of each culture
were saved for virus titration to verify infection status.
Non-SILAC-labeled cells were individually processed. For
comparative SILAC assays, equivalent numbers of L and
H cells in each experimental run were confirmed to con-
tain equivalent amounts of protein by BCA™ Protein Assay
(Pierce; Rockford, IL) and were mixed together 1:1.
Harvested cells were washed 3× in >50 volumes of ice-
cold Phosphate Buffered Saline (PBS). Washed cells were
resuspended in 250 μl of ice-cold PBS supplemented with
1.5× complete™ Protease Inhibitor (Pierce) and lysed by
the addition of 1/10th volume of 5% NP-40. Cells were in-
cubated for 30 min with periodic mixing then centrifuged
at 500×g for 10 min to pellet nuclei. The supernatants
(cytosol and soluble membranes) were transferred to fresh
microfuge tubes and the nuclear pellets were resuspended
in 250 μl of PBS supplemented with 1× complete™ Prote-
ase Inhibitor + 10% sucrose + 0.44% NP-40 and nuclei re-
pelleted, with the 2nd supernatants added to the first ones.
The nuclei were then washed 4 times with 1ml of PBS +
0.25× complete™ Protease Inhibitor + 10% sucrose. Washed
nuclei were extracted by a new 2-step MS-compatible pro-
cedure [20]. Briefly, nuclei were resuspended in 150 μl of
High Salt Extraction Buffer (620 mM NaCl, 1 mM DTT,
1 mM MgSO4, 10 mM HEPES, pH 8.0), freeze-thawed,
sonicated, insoluble material pelleted at 17,000×g for 10
min, and the supernatants transferred to fresh microfuge
tubes. The insoluble pellets were resuspended in 50 μl of 8
M urea, freeze-thawed, sonicated, insoluble material
pelleted at 17,000×g for 10 min, and the 2nd supernatants
combined with the first.
Protein content in each fraction was determined by
BCA Protein Assay (Pierce) and bovine serum albumin
standards. The cytosolic and nuclear fractions were
stored at -80°C until further processing took place.
Immunoblotting
Equivalent cytosolic and nuclear fractions were re-
solved by either 10% linear mini sodium dodecyl sulfate
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6.5 × 0.1 cm)) at 180 V for 60 min. or in 4-16% gradient
SDS-PAGE (8.0 × 16.0 × 0.1 cm) at 20 mA per gel for 5.5
hours (or overnight for a cumulative total of 110 mAhr per
gel). Proteins were transferred to 0.2 μm polyvinylidene
difluoride (PVDF) membranes at 20 V for 40 min with a
Semi-dry apparatus (BioRad), and protein transfer was con-
firmed by Ponceau-S staining. The membranes were
blocked with 5% (w/v) skim milk in Tris-buffered saline
with Tween-20 (TBST; 50 mM Tris, 150 mM NaCl, 0.05%
Tween 20, pH 7.4) and probed with various primary anti-
bodies. Primary antibodies were: in-house produced rabbit
anti-reovirus, α- GAPDH (Cell Signaling, cat#2118), α-Mx1
(Ori-Gene # TA308496), α-PARP (Cell Signaling, cat#9541),
α-ISG15 (Rockland, cat#200-401-438), α-IFIT (Abcam,
cat#ab55837), and α-SAMD9 (Sigma, cat#HPA021318);
and mouse α-Actin (Sigma, cat#A5441) and anti-STAT1
(Cell Signaling, cat#9176). Appropriate secondary horse-
radish peroxidase (HRP)-conjugated rabbit anti-mouse or
goat anti-rabbit (Cell Signaling, cat#7076, cat#7074, re-
spectively) were used to detect immune complexes. Bands
were developed by enhanced chemiluminescence and im-
aged with an Alpha Innotech FluorChemQ MultiImage III
instrument.
Comparative SILAC analyses
Protein digestion and peptide fractionation
After protein concentration determinations, SILAC-labeled
samples were diluted with freshly made 100 mM ammo-
nium bicarbonate to concentrations of ~1 mg/ml and
pH ~8. Three hundred μl of each sample (~300 μg of
protein) were reduced with dithiothreitol (DTT), alkylated
with iodoacetic acid, quenched with additional DTT, and
trypsin-digested overnight at 37°C with 6 μg of sequencing
grade trypsin (Promega, Madison, WI) as previously de-
scribed [19]. Digests were dried.
Tryptic peptides were fractionated by an orthogonal 2-
dimensional reverse-phase (RP) high pH – RP low pH pro-
cedure [50,51]. Lyophilized tryptic digests were dissolved
in 200 μl of 20 mM ammonium formate pH 10 (Buffer A),
injected onto a 1×100 mm XTerra (Waters, Milford, MA)
column and fractionated with a 0.67% acetonitrile per mi-
nute linear gradient (Agilent 1100 Series HPLC system,
Agilent Technologies, Wilmington, DE) at a flow rate of
150 μL/min. Sixty 1-min fractions were collected (cov-
ering ~40% acetonitrile concentration range) and con-
catenated [51,52], with the last 30 fractions combined with
the first 30 fractions in sequential order (i.e. #1 with #31;
#2 with #32, etc.). Combined fractions were vacuum-dried
and re-dissolved in buffer A for the second dimension RP
separation (0.1% formic acid in water).
A splitless nano-flow Tempo LC system (Eksigent,
Dublin, CA) with 20 μL sample injection via a 300 μm×
5 mm PepMap100 pre-column (Dionex, Sunnyvale, CA)and a 100 μm×200 mm analytical column packed with
5 μm Luna C18(2) (Phenomenex, Torrance, CA) were
used in the second dimension separation prior to MS ana-
lysis. Both eluents A (water) and B (acetonitrile) contained
0.1% formic acid as an ion-pairing modifier. A 0.33%
acetonitrile per minute linear gradient (0-30% B) was used
for peptide elution, providing a total 2-hour run time for
each of the 30 concatenated samples.
Mass spectrometry, bioinformatics, and data mining
A QStar Elite mass spectrometer (Applied Biosystems,
Foster City, CA) was used in a data-dependent MS/MS
acquisition mode. One-second survey MS spectra were
collected (m/z 400-1500) followed by MS/MS measure-
ments on the 3 most intense parent ions (80 counts/sec
threshold, +2 - +4 charge state, m/z 100-1500 mass
range for MS/MS), using the manufacturer’s “smart exit”
(spectral quality 5) settings. Previously targeted parent
ions were excluded from repetitive MS/MS acquisition
for 60 sec (50 mDa mass tolerance) and the bias correc-
tion option was used to correct for small pipetting er-
rors. Raw data files (30 for each of the 4 experimental
run samples) were submitted for simultaneous search
using standard SILAC settings for QStar instruments
and were analyzed by Protein Pilot®, version 4.0, using
the non-redundant human gene database (NCBInr, re-
leased March 2011, downloaded from ftp://ftp.ncbi.nih.
govrefseqH_sapiensmRNA_Prot, containing 37,391 en-
tries). Proteins, their confidences, and their expression
ratios, expressed as infected: mock (I:M), were returned
with gi accession numbers. Only proteins for which at
least 2 fully trypsin digested L and H peptides were
detected at >99% confidence were used for subsequent
comparative quantitative analyses. The false discovery
rate (FDR), defined as the percentage of reverse proteins
identified against the total protein identification, was de-
termined to be < 0.8%.
Each of the 4 datasets were normalized, essentially as
described [53] to allow dataset merging and comparison.
Briefly, every I:M ratio was converted into log space to
determine geometric means and standard deviations in
each dataset. Every protein’s log2 I:M ratio was then
converted into a z-score, using the formula:
Z−score σð Þ of b½  ¼
Log2I:M b½ –Average of
log2 of each member; a…:nð Þ
Standard deviation of
log2 of each member; a…:nð Þ
where “b” represents an individual protein in a dataset
population a….n, and z-score is the measure of how many
standard deviation units (expressed as “σ”) that protein’s
log2 I:M ratio is away from its population mean. Thus, a
protein with a z-score > 1.960σ indicates that protein’s
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> 2.576σ indicates outside the 99% confidence level, and
3.291σ indicates 99.9% confidence. Z-scores >1.960 were
considered significant. Proteins that obtained significant
positive z-scores in one labeling experiment, but that also
obtained significant negative z-scores in the reciprocal
labeling experiment were assumed to be contaminants,
were removed from analysis, and z-scores iteratively
re-calculated. Gi numbers of all significantly regulated pro-
teins were converted into HGNC identifiers by Uniprot
(http://www.uniprot.org/) and HGNC terms were submit-
ted to and analyzed by STRING [54,55] and by the DAVID
bioinformatic suite at the NIAID, version 6.7 [56,57] and
gene ontologies examined with the “FAT” datasets. The gi
numbers were also submitted to, and pathways constructed
with, Ingenuity Pathway Analysis software (IPA™).
Results and discussion
T3D replicates in HeLa cells
Reoviruses are routinely cultured and titrated in mouse






















Figure 1 Confirmation of HeLa cell infectivity. A, HeLa cells were mock
(bottom). Cells were imaged at indicated times post-infection (labeled at to
a Canon A700 digital camera. Images were imported into Adobe and sligh
image context. Scale bar is 50 μm. B, Kinetics of virus production (▼) and
with T3D. Error bars represent standard error of the mean from 2 or moreHeLa cells [35]. We evaluated the time course and con-
firmed the capacity of T3D to enter and replicate in HeLa
cells, and to cause cytopathic effect (CPE), under various
infection conditions (Figure 1). Phase-contrast microscopy
indicated mock-infected cells showed no evidence of virus
infection and CPE was not noticeable until almost a
week later, presumably due to nutrient deprivation.
T3D-infected HeLa cells also showed little, if any, notice-
able CPE until approximately 72 hpi (Figure 1A). Differ-
ences in CPE were detectable by trypan blue exclusion,
with mock-infected cells showing gradual loss of cell via-
bility from 0 to 72 hpi (Figure 1B). Differences in trypan
blue-measured cell viability between the mock- and T3D-
infected samples began to manifest at 24 hpi and became
more apparent later (Figure 1B). Virus titers initially de-
clined, corresponding to virus uncoating, and began to in-
crease after 6 hpi, was exponential from 6 to 36 hpi, and
plateaued after this point. Thus, we elected to use an ini-
tial MOI of 7, the same amount of virus used in our earlier
quantitative proteomic analyses [19-21], and to examine






















-infected (top), or infected with MRV strain T3D at an MOI of 7
p) with a Nikon TE-2000 inverted microscope and photographed with
t adjustments made in brightness and contrast, that did not alter
cell viability after HeLa cells were infected (○) or mock-infected (●)
replicates.
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meaningful comparison to these other studies.
Identification of altered host proteins
HeLa cells were infected (or mock) in duplicate and
purified cytosolic and nuclear fractions obtained. Viruses
generally induce profound alterations in infected cells.
To rule out the possibility that infection might lead to
profound alterations, including significant nuclear leak-
age by 24 hpi, which could affect our interpretations of
protein localization, we determined the distribution of
annotated nuclear proteins within each of our L-labeled
cytoplasmic fractions (Additional file 1: Figure S1). 922
of the 2137 (43.1%) L-labeled proteins in the mock-
infected cytoplasmic sample had GO nuclear annota-
tions, whereas 43.6% of the 1583 L-labeled proteins in
the infected cytoplasmic sample had GO nuclear annota-
tions, suggesting no significant nuclear leakage by 24 hpi
in the infected samples. 2D-HPLC/MS processing of the
mixed samples identified 73,969 H:L peptide pairs, cor-
responding to 3230 proteins, at ≥99% confidence. 2067
proteins were found in the cytosolic fraction in experi-
mental run #1 and 2787 were present in the run #2 cyto-
solic fraction (Table 1). Exclusion of those proteins
identified by only a single peptide, as well as those that
probably represent contaminants (see next paragraph),
further reduced the number of identified proteins to
1981 in the run #1 cytosolic fraction (Table 1; Figure 2A).
Using similar criteria, we analyzed 2651 proteins in the
reciprocally-labeled cytosolic fraction (run #2) and 653
and 711 nuclear proteins (Table 1; Figure 2A).
Each protein’s infected-to-mock (I:M) H:L or L:H ratio
was converted into a z-score to normalize the data and
facilitate comparisons of each dataset as described in
Materials and Methods (and in [19]). A number of pro-
teins were found to have significantly high or low log2Table 1 Number of peptides, proteins, log2 Infected: Mock (I:
SILAC-measured HeLa cell proteins after T3D infection
Run
Total number of peptide pairs1 22,59
Total number of proteins2 2,06
Number of proteins analysed3 1,98
Mean Log2 I:M ratios 0.014
Standard deviation of Log2 I:M ratios 0.338
Number of proteins at Z-score cutoff of: ± 1.960σ (95%) 33, 2
± 2.576σ (99%) 24, 1
± 3.291σ (99.9%) 14,
1 Total number of H:L peptide pairs for all proteins identified at confidence level ≥
2 Total number of proteins identified at confidence level ≥ 99%.
3 Number of proteins analyzed after those identified by only a single peptide, as we
4 First value is number of up-regulated proteins outside the indicated confidence le
indicated confidence level.values and corresponding z-scores in either the H:L or
L:H labeling scheme, but z-scores that were significantly
regulated in the opposite direction in the reciprocal label-
ing experiment. These included hornerin, keratins, some
S100 calcium-binding proteins, and some other proteins
(Additional file 2: Table S1; rows 3111-3243). These sig-
nificant reciprocal values could arise if, for example, ex-
ogenous unlabeled (= L-labeled) proteins were introduced
during processing. Thus, such proteins were assumed to
represent possible contaminants and were removed from
further analysis. Z-scores were iteratively recalculated until
all probable contaminants had been removed.
Stratification of each protein’s I:M ratio and its corre-
sponding z-score indicated that numerous proteins in
each sample could be considered significantly regulated.
For example, of the 1987 proteins identified in the cyto-
solic run #1 preparation, 33 were up-regulated at 95%
confidence and 14 were also up-regulated at 99.9%
confidence (Table 1). Twenty-two proteins in the same
dataset were down-regulated at 95% confidence, and
seven of these proteins were also down-regulated at
99.9% confidence. Inspection of protein I:M ratios and
z-scores indicated that most proteins differentially re-
gulated at >95% confidence had I:M ratios altered by
> 1.6-fold. Thus, for proteins observed multiple times,
we applied several filtering levels. We considered them
significantly regulated if at least one of their observa-
tions had a z-score ≥ 1.960σ, if the other observation in
the same type of fraction (cytosolic or nuclear) was no
more than 0.75σ in the opposite direction, if most of the
peptides used to determine the protein regulation were
differentially regulated at >95% confidence, if peptide
regulation variability, as measured by standard error of
the mean, was relatively small, and if the average I:M
ratio was > 1.6-fold. Application of these filters resulted
in removal of several proteins which might otherwiseM) ratio means and standard deviation, and Z-scores of
Cytosol Nuclei
#1 Run #2 Run #1 Run #2
1 34,393 8,011 8,974
7 2,787 670 728
7 2,684 635 686
7 0.0126 0.0004 0.0187
2 0.4211 0.4664 0.3423
24 50, 20 7, 4 20, 12
1 29, 11 5, 2 14, 8
7 23, 8 2, 2 8, 4
99%.
ll as possible contaminants, removed.
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Figure 2 (See legend on next page.)
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(See figure on previous page.)
Figure 2 Distributions of proteins identified in various experiments. A, Venn diagram of numbers of identified proteins from various analyses.
B, Frequency distributions of identified proteins in both cytosolic sample sets, with I:M ratios expressed as Log2 values. Positive values represent
up-regulated host proteins in virus-infected cells; negative values represent down-regulated host proteins. C, Frequency distributions of identified
proteins in both nuclear sample sets. Note that distributions are not identical, with different numbers of proteins differentially expressed away from the
Figure 2 (See legend on next page.)
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mitochondria-associated granulocyte macrophage CSF sig-
naling molecule (gi|27363461) had an I:M ratio of 1.63
(Additional file 2: Table S1; row 3133) but was excluded
because two peptides had measured I:M ratios of ~1.22
and one peptide had a measured ratio of 100 (STD =
12.64). For proteins observed a single time, they were con-
sidered significantly regulated if the z-score was ≥ 1.960σ
and if the I:M ratios were altered > 1.6-fold. Using the
above criteria, we identified and measured 45 proteins that
were significantly up-regulated and 19 proteins that were
significantly down-regulated in the cytosolic fraction and
16 proteins that were significantly up-regulated and 9 pro-
teins that were significantly down-regulated in the nuclear
fraction (Table 2).
HeLa cell proteins up-regulated by T3D infection are
associated with defense responses, immune responses,
macromolecular binding, regulation of immune effector
processes, and responses to virus
Proteins, and their levels of regulation, were analyzed sev-
eral ways. Protein gi numbers were imported into Uniprot
(http://www.uniprot.org/) and converted into HUGO no-
menclature committee (HGNC) identifiers. Significantly
up-regulated and down-regulated proteins (95% confidence
interval) were then imported into DAVID [56,58] and gene
ontologies identified (Figure 3).
Up-regulated proteins were assigned to 42 GOTERM
biological processes at 95% confidence (Figure 3, upper),
that included responses to viruses, immune responses,
defense responses, regulation of immune effector pro-
cesses and numerous related processes. Up-regulated pro-
teins were also assigned to 23 functional groups (Figure 3,
middle) including primarily macromolecular binding and
transcription cofactor and nucleotidyltransferase activities.
Protein HGNC identifiers were also uploaded into
STRING [54,55] and interactions depicted (Figure 4B,
left). Many immunomodulatory proteins (ie. MX1, MX2,
ISG15, various IFITs and various OAS molecules) form
a major interacting cluster and interact either directly or
indirectly with numerous other regulated proteins.
Protein gi numbers and levels of regulation were also
imported into the Ingenuity Pathways Analysis (IPA™) tool
to build interacting pathways. IPA indicated up-regulated
proteins were enriched in cytokines, growth factors, tran-
scription regulators and transmembrane receptors. IPA
identified 8 interacting pathways at a confidence level of95% or greater. Four of these pathways, each with 12 or
more “focus” members (significantly up- or down-
regulated proteins), shared common members and it was
possible to build a single, merged pathway (Figure 4B,
middle). Other pathways contained 2 or fewer focus mole-
cules. The four major pathways were those involved in
antimicrobial response, inflammatory response, infectious
diseases, dermatological diseases and conditions, cell-to-
cell signaling and interaction, cell cycle, and cell death.
Regulated proteins identified in each of the purified cyto-
solic and nuclear fractions were overlaid onto each net-
work (Figure 4C–F). Proteins identified in our analyses as
up-regulated and present in the pathways are depicted in
shades of red. Some proteins, such as IFI16, ISG15, SP100,
and STAT1, were highly regulated in both the cytosol and
the nucleus, whereas some, such as IFIT1, Mx1, and
TRIM21, were up-regulated in one fraction but not the
other. Many of the identified regulated proteins also are
involved in several known canonical pathways, including
interferon signaling (Figure 5), glycogen degradation, pat-
tern recognition receptors, PDGF signaling, antigen pres-
entation, protein ubiquitination, and others (Additional
file 3: Figure S2). Many of the highly up-regulated pro-
teins, such as STAT, ISG15 and Mx1 also represent inter-
action nodes within various pathways, interacting with
numerous other proteins. Many of these proteins play
important roles in innate immunity. In addition, the
Mx proteins, which are large GTPase dynamin-like
interferon-induced molecules, are important anti-viral
proteins, particularly against RNA viruses [59,60]. These
have been identified as up-regulated by various virus
infections, including by influenza [4,7,61] and by reovi-
ruses [62-64].
To both validate some of the SILAC data, as well as
determine temporal expression of various immune-
modulated proteins, we harvested T3D-infected HeLa
cells at various times, extracted the cytosolic and nuclear
fractions, and immuno-probed for various molecules
(Figure 6). Most Western blot results confirmed the
SILAC-determined results (Figure 6A). For example,
STAT1 was measured as up-regulated in both the cyto-
plasmic as well as nuclear fractions by SILAC and West-
ern blot of both fractions confirmed these results. A few
differences in the specific measured ratios (for example,
SILAC indicated STAT1 was up-regulated 3.2–fold in
the cytoplasm, but Western blot densitometry suggested
the increase was approximately 5–fold) probably reflect
Table 2 Significantly-regulated HeLa cell proteins after T3D infection
Run # 1 (H:L) Run # 2 (L:H)
Accession HGID Name Inf /
Mock
(±S.E.M.) # Pep % Cov Z-Score # Pep % Cov Z-score
Cytoplasmic
Up-regulated
Measured more than once
gi|222136619 MX1 myxovirus resistance protein 1 9.76 0.52 8 55.9 10.925 23 51.7 7.427
gi|94536771 CCD56 coiled-coil domain containing 56 5.48 1.62 5 56.6 0.223 3 20.7 15.154
gi|27881482 DDX58 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide
RIG-I
4.76 0.83 3 27.7 7.191 12 23.2 5.203
gi|72534658 IFIT3 interferon-induced protein with tetratricopeptide
repeats 3
4.65 0.39 4 25.3 7.260 14 46.9 5.067
gi|4826774 ISG15 ISG15 ubiquitin-like modifier 4.60 0.51 14 47.3 6.164 14 53.9 5.442
gi|116534937 IFIT1 interferon-induced protein with tetratricopeptide
repeats 1 isoform 2
3.80 1.36 2 40.4 11.782 8 25.1 3.308
gi|156105693 PR285 PPAR-alpha interacting complex protein 285
isoform 1
3.45 1.53 2 22.0 5.564 5 10.6 4.109
gi|153082755 IFIT2 interferon-induced protein with tetratricopeptide
repeats 2
3.37 0.81 3 33.7 1.291 11 33.1 4.978
gi|6274552 STAT1 signal transducer and activator of transcription 1
isoform alpha
3.23 0.39 13 44.4 4.386 34 50.4 4.170
gi|45007007 OAS3 2'-5'oligoadenylate synthetase 3 3.00 0.32 4 19.5 4.560 9 17.3 3.761
gi|208973246 DHPR quinoid dihydropteridine reductase 2.40 0.48 2 27.9 0.693 4 20.5 4.171
gi|38201706 SAMD9 sterile alpha motif domain containing 9 2.15 0.48 1 18.8 2.560 10 15.4 2.648
gi|4506103 E2AK2 eukaryotic translation initiation factor 2-alpha
kinase 2
1.97 0.72 3 45.7 2.503 10 16.2 2.374
gi|24307901 IFI35 interferon-induced protein 35 1.92 0.44 3 29.2 2.119 5 18.4 2.508
gi|166706903 GBP1 guanylate binding protein 1, interferon-inducible,
67 kDa
1.85 0.88 5 25.7 1.682 11 27.2 2.393
gi|5031863 LG3BP galectin 3 binding protein 1.81 0.86 6 19.5 1.731 12 29.2 2.303
gi|22035653 APOL2 apolipoprotein L2 1.80 0.53 4 30.3 1.501 6 32.6 2.507
gi|27477136 ZCCHV zinc finger antiviral protein isoform 1 1.80 0.69 2 26.2 2.245 16 25.5 2.007
gi|20270303 MIRO2 ras homolog gene family, member T2 1.79 0.92 2 15.7 9.955 6 15.7 −0.055
gi|4757876 BST2 bone marrow stromal cell antigen 2 1.68 0.38 5 19.4 1.610 5 18.3 2.201
gi|188528628 PNPT1 polyribonucleotide nucleotidyltransferase 1 1.63 0.20 13 47.6 2.221 24 36.8 1.575
Measured once
gi|156415992 ATP8* transcription factor B1, mitochondrial 84.09 0.71 2 9.2 15.154
gi|4557321 APOA1 apolipoprotein A-I preproprotein 7.99 0.97 2 23.2 7.089
gi|11342664 MX2 myxovirus resistance protein 2 7.72 0.57 6 11.3 6.972
gi|4502511 CO9 complement component 9 precursor 7.26 4.88 2 5.0 6.760
gi|166706909 IF44L interferon-induced protein 44-like 6.18 3.89 3 15.9 6.211
gi|74229015 OAS1 2',5'-oligoadenylate synthetase 1 isoform 3 5.85 0.86 3 11.6 6.024
gi|19923717 DTX3L deltex 3-like 3.68 3.31 4 9.7 4.438
gi|74229019 OAS2 2'-5'-oligoadenylate synthetase 2 isoform 1 3.50 2.14 2 4.9 4.263
gi|41350201 EPN1 epsin 1 isoform c 3.20 2.53 2 5.5 3.953
gi|5174751 YAP1 Yes-associated protein 1, 65 kD 3.12 1.32 3 7.9 3.867
gi|222831595 DDX60 DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 2.92 1.56 5 7.6 3.636
gi|15208660 RO52 tripartite motif protein 21 2.69 0.63 8 22.7 3.364
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Table 2 Significantly-regulated HeLa cell proteins after T3D infection (Continued)
gi|110825982 HERC5 hect domain and RLD 5 2.50 0.86 2 4.7 3.104
gi|4557499 CTBP2 C-terminal binding protein 2 isoform 1 2.49 1.36 7 25.8 3.093
gi|4506191 PSMB10 proteasome beta 10 subunit proprotein 2.21 0.71 2 7.3 2.688
gi|73747915 TAP2 transporter 2, ATP-binding cassette, sub-family B
isoform 1
2.16 0.70 3 10.8 2.615
gi|38016914 SAMH1 SAM domain- and HD domain-containing
protein 1
2.16 0.48 6 21.7 2.610
gi|126012562 LRP1 low density lipoprotein-related protein 1 2.11 0.60 3 2.9 2.529
gi|4503445 TYPH endothelial cell growth factor 1 (platelet-derived)
precursor
2.10 0.85 2 18.1 2.504
gi|6912630 IFIT5 interferon-induced protein with tetratricopeptide
repeats 5
2.05 0.63 3 13.9 2.435
gi|112789562 IF16 interferon, gamma-inducible protein 16 1.95 0.64 6 21.8 2.263
gi|45580709 UN93B unc-93 homolog B1 1.93 0.77 2 4.2 2.231
gi|9665248 TAP1 transporter 1, ATP-binding cassette, sub-family B 1.88 0.78 2 11.8 2.135
gi|52630342 HLA-C major histocompatibility complex, class I,
C precursor
1.80 0.34 20 45.4 1.982
Down-regulated
Measured more than once
gi|134288865 S4A7 solute carrier family 4, sodium bicarbonate
cotransporter, member 7
0.064 0.21 2 21.7 −3.832 2 3.8 −15.807
gi|29294627 PPFIBP1 PTPRF interacting protein binding protein 1
isoform 1
0.30 0.21 3 26.5 −10.860 3 11.0 0.328
gi|4506431 RASA1 RAS p21 protein activator 1 isoform 1 0.36 0.06 1 16.5 −1.418 2 1.8 −4.688
gi|5453704 PRAF3 ADP-ribosylation-like factor 6 interacting
protein 5
0.56 0.18 4 40.4 −3.941 2 29.8 0.235
gi|21956645 MTPN myotrophin 0.56 0.08 9 49.1 −4.823 8 39.0 0.091
Measured once
gi|167466177 CDC27 cell division cycle protein 27 isoform 1 0.010 0.36 2 4.0 −15.807
gi|8922549 ASF1B anti-silencing function 1B 0.33 0.000 2 23.8 −3.834
gi|33598948 PLCG1 phospholipase C gamma 1 isoform a 0.33 0.34 2 6.9 −3.803
gi|46049063 XPO6 exportin 6 0.34 0.05 2 5.2 −3.706
gi|116734706 I2BP2 interferon regulatory factor 2 binding
protein 2 isoform B
0.36 0.38 3 13.7 −3.517
gi|116686114 FERM1 kindlin-1 0.38 0.004 3 12.3 −3.348
gi|5453543 AK1C1 aldo-keto reductase family 1, member C1 0.39 0.05 14 72.8 −4.099
gi|63025188 HERC4 hect domain and RLD 4 isoform a 0.41 0.000 2 2.5 −3.077
gi|14589951 RPAB1 DNA directed RNA polymerase II polypeptide E 0.46 0.14 6 21.4 −2.683
gi|51317370 NDUA6 NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex, 6, 14 kDa
0.47 0.000 2 14.9 −2.637
gi|10190746 RDH14 retinol dehydrogenase 14 (all-trans and 9-cis) 0.51 0.38 2 8.6 −2.306
gi|13236559 MMTA2 hypothetical protein LOC79169 0.54 0.01 2 35.0 −2.138
gi|115430235 UHRF1 ubiquitin-like with PHD and ring finger domains
1 isoform 1
0.55 0.10 2 11.1 −2.105
gi|71773010 AP1G1 adaptor-related protein complex 1, gamma 1
subunit isoform a
0.55 0.25 4 22.3 −2.570
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Table 2 Significantly-regulated HeLa cell proteins after T3D infection (Continued)
Nuclear
Up-regulated
Measured more than once
gi|4826774 ISG15 ISG15 ubiquitin-like modifier 4.05 0.40 5 42.4 4.065 4 23.0 6.275
gi|19923236 SP100 nuclear antigen Sp100 isoform 2 2.96 0.93 4 18.1 2.812 8 26.2 4.880
gi|112789562 IF16 interferon, gamma-inducible protein 16 2.92 0.40 2 11.8 2.384 6 19.3 4.879
gi|67089149 PML promyelocytic leukemia protein isoform 1 2.34 0.60 2 8.4 2.758 9 21.7 3.496
gi|4757876 BST2 bone marrow stromal cell antigen 2 2.03 0.56 3 18.3 2.512 2 13.9 2.290
Measured once
gi|4503253 DAD1 defender against cell death 1 5.22 0.62 3 17.7 5.110
gi|188219599 NMI N-myc and STAT interactor 4.33 1.17 2 16.9 6.125
gi|24307901 IFI35 interferon-induced protein 35 3.60 0.93 3 15.6 5.347
gi|4758024 COIL coilin 2.46 0.83 2 12.8 2.788
gi|5453690 DNJB1 DnaJ (Hsp40) homolog, subfamily B, member 1 2.32 0.000 2 11.8 3.499
gi|58530840 DESP desmoplakin isoform I 2.09 0.91 3 9.3 3.054
gi|156104878 GLSK glutaminase 2.03 0.75 3 4.8 2.931
gi|27477136 ZCCHV zinc finger antiviral protein isoform 1 1.95 0.74 2 2.2 2.754
gi|4507951 1433F tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, eta
polypeptide
1.89 1.06 2 22.8 2.633
gi|5901998 LSM6 Sm protein F 1.85 0.60 3 56.3 2.538
gi|4506003 PP1A protein phosphatase 1, catalytic subunit, alpha
isoform 1
1.70 0.95 4 13.9 2.184
Down-regulated
Measured more than once
gi|55953087 NOG1 G protein-binding protein CRFG 0.10 0.21 2 4.4 −13.385 2 6.3 −1.353
gi|4503453 EDF1 endothelial differentiation-related factor 1
isoform alpha
0.63 0.17 4 28.4 −0.672 4 41.2 −2.991
gi|4507555 LAP2A thymopoietin isoform alpha 0.64 0.03 10 15.3 −2.464 10 12.5 −0.479
Measured once
gi|88853069 VTNC vitronectin precursor 0.013 0.04 2 4.8 −13.385
gi|25777615 PSD7 proteasome 26S non-ATPase subunit 7 0.39 0.30 3 12.3 −4.046
gi|4757732 AIFM1 programmed cell death 8 isoform 1 0.40 0.18 2 18.4 −3.870
gi|57863257 TCPA T-complex protein 1 isoform a 0.50 0.04 2 5.2 −2.951
gi|4506701 RS23 ribosomal protein S23 0.54 0.19 4 32.9 −2.647
gi|151108473 FIS1 tetratricopeptide repeat domain 11 0.63 0.000 2 7.2 −1.990
*: Obsolete record; removed from NCBI database.
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addition, SILAC suggested the relative levels of PARP
were essentially unchanged, although Western blot sug-
gested a small decrease in cytoplasmic levels and nuclear
fractions demonstrated PARP cleavage (Figure 6A). Kin-
etic analyses revealed more details. Reovirus proteins
were not detected at early time points but became de-
tectable by 18 hpi. STAT-1, an important effector pro-
tein that plays a key role in numerous canonicalpathways (Figure 5; Additional file 3: Figure S2), and that
was found up-regulated in both the cytoplasmic as well
as nuclear fractions by SILAC (Figure 6A; Table 2), was
detected in mock-infected cells as well as in infected
cells. STAT-1 expression appeared to remain constant
until 9 hpi, and then increased from 9 hpi onward,
reaching levels about 3-fold higher at 24 hpi in the cyto-
plasm compared to mock and about 6-fold higher at
later time points. Significant STAT1 increases were seen
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Figure 3 Gene ontology analyses of up-regulated and down-regulated proteins. Sets of up- and down-regulated proteins identified in
Table 2 were separately imported into the DAVID gene ontology suite of programs at the NIAID, gene identifications converted by that program,
and ontological functions determined by GOTERM.







Figure 4 (See legend on next page.)
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Figure 4 Molecular pathways of regulated proteins. Proteins and their levels of regulation were imported into the Ingenuity Pathways
Analysis (IPA™) tool and interacting pathways were constructed. A, Ontological classifications of all measured proteins (Total) as well as those
significantly up- and down-regulated. B, Merged networks, determined by uploading the regulated proteins only into STRING [54,55] (left), or by
uploading all molecules and their degree of regulation into IPA™ (middle). C-F, The top 4 IPA networks, identified at 95% confidence and each of
which contained 12 or more “focus” molecules (molecules significantly up- or down-regulated), with pathway names indicated. Solid lines: direct
known interactions; dashed lines: suspected or indirect interactions. Significantly regulated proteins identified in either the cytosolic or nuclear
fractions were overlaid onto each network; red: significantly up-regulated proteins; pink: moderately up-regulated proteins; grey: proteins
identified but not significantly regulated; light green: moderately down-regulated proteins; dark green: significantly down-regulated proteins;
white: proteins known to be in network, but not identified in our study.
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larly, expression of Mx1 was detected in mock and at
early times in infected cells and began to increase at 9
hpi, reaching ~8-fold higher levels by 24 hpi (Figure 6B).
Mx1, IFIT1, and ISG15 were detected in cytoplasmic
fractions and showed clear up-regulation by 18 hpi (by 9
hpi in the case of Mx1 and IFIT1) (Figure 6B), but none of
these three proteins were detected in nuclear fractions at
any time point up to 48 hpi (data not shown). PARP, cleav-
age of which serves as an apoptosis marker, demonstrated
increased cleavage in both the cytoplasm and the nucleus
as early as 2 hpi and this cleavage appeared to wane by
about 18-24 hpi, shortly after reovirus proteins became
detectable and shortly after the other discussed proteins
started to increase, consistent with known interactions be-
tween these and other innate immune and inflammatory
response molecules [65-67].Figure 5 Significantly affected canonical pathway “Interferon signalin
regulated proteins, light green indicates down-regulated, grey represents n
part of the pathway but not identified by SILAC.HeLa cell proteins down-regulated by T3D infection are
associated with cell death, macromolecular catabolic
processes, and tissue development
DAVID assigned down-regulated proteins to 18 biological
processes at 95% confidence (Figure 3, lower), that included
ubiquitination regulation, cell adhesion regulation, macro-
molecular complex assembly and catabolic processes. IPA
indicated down-regulated proteins were enriched in transla-
tion regulation and transporter factors (Figure 4A). Many
down-regulated proteins also are related to mitochondrial
dysfunction (Additional file 3: Figure S2). Many other pro-
teins, such as EIF4G3, FERMT1, CDC27 and COIL were
mapped to the cytoplasmic fractions (Figure 4E, F).
An apparent down-regulation in protein levels in either
of the sub-cellular fractions examined could represent re-
duced protein biosynthesis, protein degradation, redistribu-
tion of proteins from one fraction to another, or variousg”, as determined by IPA™ analysis. Red indicates highly up-
ot significantly affected, and white represents molecules known to be
AB
Figure 6 (See legend on next page.)
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Figure 6 Western blot validation of host protein regulation. A, HeLa cells were mock-infected or infected for 24 h, or B, for indicated periods
of time, harvested and lysed with 0.5% NP-40 detergent. The cytosolic and nuclear fractions were separately purified, dissolved in SDS
electrophoresis sample buffer, and proteins resolved in 10% (A), or in 4-16% gradient (B) SDS-PAGE, transferred to PVDF, and probed with
indicated antibodies. Antibody binding was detected with HRP-conjugated secondary antibodies and ECL, and visualized with an Alpha Innotech
FluorChemQ MultiImage III instrument. Molecular weight standards are indicated at left and SILAC-measured ratios are indicated on right in A.
*: not detected in indicated fraction; †: based on single peptide only.
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manifested by the same protein apparently being up-
regulated in one compartment at the same time it appeared
down-regulated in the other compartment. While there
were numerous proteins that were detected as either up-
regulated or down-regulated in one compartment and un-
affected in the other compartment (i.e. IFIT3, MX2, PML,
RASA1, XPO6) there were very few proteins detected that
were up-regulated in one compartment and simultaneously
down-regulated in the other. For example coilin (COIL)
was found up-regulated about 2.5-fold in purified nuclear
fractions, based upon 2 peptides; however, it appeared
down-regulated by about 2-fold, but only based upon a sin-
gle peptide (Additional file 2: Table S1). This molecule is an
integral component of nuclear suborganelles called Cajal
bodies that play roles in small RNA post-transcriptional
modifications [68,69]. More detailed analyses of fates of
various proteins, with regards to the possible altered bio-
synthesis, degradation and redistribution as a result of virus
infection, are warranted.Similarities and differences between HeLa cell and
HEK293 cell protein responses to reovirus infection
Transcriptomic responses to T3D infection have been pre-
viously reported [40]. That study identified more than 100
interferon- and NF-κB-responsive genes that were either
positively or negatively regulated by T3D infection. We
identified and measured 30 of these genes’ proteins and
assessed correlation between the mRNA and protein
levels. There was good correlation for some genes and
proteins. For example, OAS1 and PML mRNA and pro-
tein levels were highly up-regulated, 9 other proteins we
identified as up-regulated also had up-regulated mRNA
levels, although the degree of up-regulation differed, and
some proteins and genes (i.e. UBC and POLD1) were simi-
larly non-regulated or only slightly down-regulated. Ana-
lysis of the 30 proteins after assigning proteins and genes
to highly-up, slightly-up, non-regulated, slightly-down and
highly-down regulated classes resulted in an r2 correlation
of 0.62 (data not shown), slightly higher than what has
been found in other studies that correlate mRNA levels to
protein levels [3,4]. Unfortunately, most mRNAs and pro-
teins could not be compared because the other ~70
interferon- and NF-κB-responsive genes reported by
O’Donnell et al. [40] were not found by us.We previously determined HEK293 responses to
reovirus T1L infection [21]. That study identified and
measured 2992 proteins at 24 hpi, 104 of which were up-
regulated and 49 of which were down-regulated. Only
194 (~ 6.5%) of these same proteins were identified in
the current study (Additional file 1: Figure S3). A small
number of proteins were similarly regulated by both vi-
ruses in both cell types. Most proteins (159-187, de-
pending upon how cutoffs were set) were non-regulated
in both cell types, and no proteins were up-regulated in
one cell but down-regulated in the other (Additional
file 1: Figure S3C). Although there was only ~6.5% over-
lap between the 2 protein datasets, which could repre-
sent differences in the virus used and/or in the type
of cell analyzed, many of the highly regulated pathways
and processes were similar between the two experimen-
tal conditions. For example, regulation of interferon
signaling, immunomodulation and responses to virus
were highly up-regulated in both studies. Only 5 of the
194 host proteins identified and measured in both the
T1L-infected HEK-293 and T3D-infected HeLa cells
were significantly regulated. Of these, only 1 (STAT1),
discussed in more detail earlier, was significantly regu-
lated by both cell/virus conditions, being up-regulated
2.1-fold in T1L-infected HEK293 cells and up-regulated
3.2-fold in T3D-infected HeLa cells. One other protein
(SCO1) was up-regulated 8.4-fold in T1L-infected HEK-
293 cells but only moderately up-regulated (1.4-fold,
Z-score = 1.088σ) in T3D-infected HeLa cells. SCO1 is
a metallochaperone involved in copper homeostasis and
found in the mitochondrial intermembrane space [70].
The SCO genes appear evolutionarily conserved [71]
and have not yet been reported to have roles in
virus replication. Two proteins were significantly up-
regulated in one cell type but not regulated in the other.
PRKCDBP, a potential tumor suppressor gene [72], and
COMT, a degradative methyltransferase [73] that has been
associated with cognitive deficits in herpes simplex type 1
virus infections [74], were up-regulated 2.3-, and 3.1-fold,
respectively, in T1L-infected HEK-293 cells. However, the
COMT ratio is based upon a single measured peptide so
less reliable. One protein was significantly down-regulated
in one cell type but not regulated in the other. PLCG1, in-
volved in immune regulated signal transduction [75], was
down-regulated 3-fold (I:M ratio of 0.33) in T3D-infected
HeLa cells. Twenty six other proteins were moderately
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~ 0.9- – 2.2-fold up-regulation; or -1.000 – -1.959σ, cor-
responding to ~ 0.9- – 1.6-fold down-regulation [I:M ra-
tios of 0.63 – 1.13) (Additional file 3: Table S2). Although
measured values were not significant, one additional pro-
tein (C2orf43), a gene that has been associated with pros-
tate cancer [76], was moderately down-regulated in both
the T1L and T3D infections, with infected:mock values of
.66 and 0.61, respectively. A few of these determined
values are based upon 1 or 2 peptides. Therefore, add-
itional work is needed to determine whether these appar-
ent similarities and differences are real and virus- and/or
cell-specific. We are currently analyzing T1L- and T3D-
infected HeLa cells labeled by the iTRAQ reagent to si-
multaneously compare multiple virus types to mock and
to use a complementary approach that may identify add-
itional regulated proteins.
In summary, this non-biased global analysis has identi-
fied numerous host proteins significantly affected by reo-
virus T3D infection. These proteins complement others
determined in other studies, fit within numerous inflam-
matory and innate immune pathways, and will provide
the starting point for more detailed kinetic studies, such
as initiated herein, as well as studies aimed at delinea-
tion of virus-specific pathways.
Additional files
Additional file 1: Figure S1. Gene ontology distribution of light-
labeled proteins in indicated samples collected at 24 hpi from Mock- and
T3D-infected HeLa cells; , nuclear-annotated proteins; , non-nuclear
-annotated proteins. Total numbers of proteins and percentages
indicated within each pie section. Figure S2. Additional top-ranked
canonical pathways identified by IPA™. Red indicates highly up-regulated
proteins, light green indicates down-regulated, grey represents not
significantly affected, and white represents molecules known to be part
of the pathway but not identified by SILAC. Figure S3. Comparison of
reovirus-induced protein identifications and regulation in HEK293 cells
[21] and in HeLa cells (this study). A, Venn diagram of numbers of
identified proteins, and their overlap, from the 2 studies. B, Dot plot
distributions of the Z-scores of each of the 194 proteins identified in
both studies. C, Comparative distributions of regulated proteins, using Z-
score category cutoffs of ± 1.960 (upper value in each cell) and ± 1.000
(lower italicized value in each cell). For example, 1 protein (STAT1) had a
Z-score > 1.960 in both the HEK293 and HeLa cell lists and 2 proteins
(STAT1 and cytochrome oxidase deficient homolog 1) had Z-scores >
1.000 in both the HEK293 and HeLa cell lists.
Additional file 2: Table S1. All identified proteins and their associated
# peptides, % coverage, Infected: Mock ratio, and calculated Z-scores a.
Additional file 3: Table S2. Common proteins regulated in either T1L-
infected HEK-293 or T3D-infected HeLa cells.
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